|
1
|
Piazuelo MB and Correa P: Gastric cancer:
Overview. Colomb Med (Cali). 44:192–201. 2013.
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuo CY, Chao Y and Li CP: Update on
treatment of gastric cancer. J Chin Med Assoc. 77:345–353. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Piazuelo MB and Correa P: Gastric cancer:
Overview. Colomb Med (Cali). 44:192–201. 2013.
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li PF, Chen SC, Xia T, et al: Non-coding
RNAs and gastric cancer. World J Gastroenterol. 20:5411–5419. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hung CH, Chiu YC, Chen CH and Hu TH:
MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression
and therapeutic target. BioMed Res Int. 2014:4864072014. View Article : Google Scholar
|
|
9
|
Qiu T, Zhou X, Wang J, et al: MiR-145,
miR-133a and miR-133b inhibit proliferation, migration, invasion
and cell cycle progression via targeting transcription factor Sp1
in gastric cancer. FEBS Lett. 588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LK, Hsiao TH, Hong TM, et al:
MicroRNA-133a suppresses multiple oncogenic membrane receptors and
cell invasion in non-small cell lung carcinoma. PLoS One.
9:e967652014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo J, Xia B, Meng F and Lou G: miR-133a
suppresses ovarian cancer cell proliferation by directly targeting
insulin-like growth factor 1 receptor. Tumour Biol. 35:1557–1564.
2014. View Article : Google Scholar
|
|
12
|
Fujiwara T, Katsuda T, Hagiwara K, et al:
Clinical relevance and therapeutic significance of microRNA-133a
expression profiles and functions in malignant
osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Akanuma N, Hoshino I, Akutsu Y, et al:
MicroRNA-133a regulates the mRNAs of two invadopodia-related
proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer.
110:189–198. 2014. View Article : Google Scholar :
|
|
14
|
Jayo A and Parsons M: Fascin: a key
regulator of cytoskeletal dynamics. Int J Biochem Cell Biol.
42:1614–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang S, Huang FK, Huang J, et al:
Molecular mechanism of fascin function in filopodial formation. J
Biol Chem. 288:274–284. 2013. View Article : Google Scholar :
|
|
16
|
Bi JB, Zhu Y, Chen XL, et al: The role of
fascin in migration and invasion of urothelial carcinoma of the
bladder. Urol Int. 91:227–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan VY, Lewis SJ, Adams JC and Martin RM:
Association of fascin-1 with mortality, disease progression and
metastasis in carcinomas: a systematic review and meta-analysis.
BMC Med. 11:522013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsai WC, Jin JS, Chang WK, et al:
Association of cortactin and fascin-1 expression in gastric
adenocarcinoma: correlation with clinicopathological parameters. J
Histochem Cytochem. 55:955–962. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fu H, Hu Z, Wen J, Wang K and Liu Y:
TGF-beta promotes invasion and metastasis of gastric cancer cells
by increasing fascin1 expression via ERK and JNK signal pathways.
Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009. View Article : Google Scholar
|
|
20
|
Fu H, Wen JF, Hu ZL, Luo GQ and Ren HZ:
Knockdown of fascin1 expression suppresses the proliferation and
metastasis of gastric cancer cells. Pathology. 41:655–660. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen MB, Wei MX, Han JY, et al:
MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression
in HT-29 colorectal cancer. Cell Signal. 26:102–109. 2014.
View Article : Google Scholar
|
|
22
|
Adammek M, Greve B, Kässens N, et al:
MicroRNA miR-145 inhibits proliferation, invasiveness and stem cell
phenotype of an in vitro endometriosis model by targeting multiple
cytoskeletal elements and pluripotency factors. Fertil Steril.
99:1346–1355. e52013. View Article : Google Scholar
|
|
23
|
Yamamoto H, Kohashi K, Fujita A and Oda Y:
Fascin-1 over-expression and miR-133b downregulation in the
progression of gastrointestinal stromal tumor. Mod Pathol.
26:563–571. 2013. View Article : Google Scholar
|
|
24
|
Chiyomaru T, Enokida H, Tatarano S, et al:
miR-145 and miR-133a function as tumour suppressors and directly
regulate FSCN1 expression in bladder cancer. Br J Cancer.
102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kano M, Seki N, Kikkawa N, et al: miR-145,
miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in
esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814.
2010. View Article : Google Scholar
|
|
26
|
Wu ZS, Wang CQ, Xiang R, et al: Loss of
miR-133a expression associated with poor survival of breast cancer
and restoration of miR-133a expression inhibited breast cancer cell
growth and invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI
|
